Anteris Technologies Global (AVR) Cash from Investing Activities (2024 - 2026)
Anteris Technologies Global (AVR) reported Cash from Investing Activities of -$182000.0 for Q1 2026, down 116.4% year-over-year from $1.1 million in Q1 2025, and up 54.16% quarter-over-quarter from -$397000.0 in Q4 2025.
Anteris Technologies Global (AVR) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has 3 years of Cash from Investing Activities data on file, last reported at -$182000.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$182000.0, down 116.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 316.78% YoY), and the FY2025 annual result was -$596000.0, up 73.86% from the prior year.
- Cash from Investing Activities climbed to -$182000.0 in Q1 2026 per AVR's latest filing, from -$397000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $1.1 million in Q1 2025 and troughed at -$772000.0 in Q3 2025.
- A 3-year average of -$339777.8 and a median of -$537000.0 in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities surged 254.81% in 2025, then sank 116.4% in 2026.
- A 3-year view of Cash from Investing Activities shows it stood at -$364000.0 in 2024, then retreated by 9.07% to -$397000.0 in 2025, then soared by 54.16% to -$182000.0 in 2026.
- Business Quant data shows AVR's Cash from Investing Activities at -$182000.0 in Q1 2026, -$397000.0 in Q4 2025, and -$772000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Anteris Technologies Global | 779.46 Mn | 779.43 Mn | 380,000.00 | -182,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182,000.00 |
| Mar 31, 2026 | -182,000.00 |
| Dec 31, 2025 | -397,000.00 |
| Dec 31, 2025 | -397,000.00 |
| Sep 30, 2025 | -772,000.00 |
| Sep 30, 2025 | -772,000.00 |
| Jun 30, 2025 | -537,000.00 |
| Jun 30, 2025 | -537,000.00 |
| Mar 31, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | -364,000.00 |
| Dec 31, 2024 | -364,000.00 |
| Sep 30, 2024 | -553,000.00 |
| Sep 30, 2024 | -553,000.00 |
| Jun 30, 2024 | -646,000.00 |
| Jun 30, 2024 | -646,000.00 |
| Mar 31, 2024 | -717,000.00 |
| Mar 31, 2024 | -717,000.00 |